How much is Qrativ worth in 2026?

Qrativ has a current valuation of N/A based on their Early Stage VC (Series A) round and secondary market data.

How much funding has Qrativ raised?

Qrativ has raised N/A in total funding across 1 funding rounds.

Qrativ

Drug Discovery

Qrativ valuation and funding history | Last updated: July 14, 2017 | 1 funding rounds

Current Valuation

N/A

As of July 14, 2017

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series A)

$8.3M

Last Funding

Jul 2017

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
July 14, 2017	Early Stage VC (Series A)	$8.3M	N/A	-

Valuation Analysis

Current Valuation Metrics

Qrativ is currently valued at N/A as of July 14, 2017.

Track Qrativ Valuation Updates

Get notified when Qrativ raises new funding or valuation changes

Explore More Data

Detailed analysis for Qrativ

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Qrativ's valuation history, funding rounds, and growth metrics.

No credit card required

What is Qrativ Worth in 2026?

Qrativ is a leading private company in the Drug Discovery sector. Track Qrativ's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Qrativ Valuation is Determined

Private company valuations like Qrativ's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.